Neural Analytics
Los Angleles, US · Founded 2013 · Delaware corporation · 2 known investors
Healthtech
Founders & leadership
Neural Analytics was founded in 2013 by Leo Petrossian.
LP
Leo PetrossianFounder
MH
Mark HattendorfExecutive
Board
YP
Yuri PikoverBoard director
RD
Roy DoumaniBoard director
KB
Kenneth BakerBoard director
SR
Stan RoweBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$81.6M disclosed across 7 rounds · 2014–2021
▶$10.3MraisedOct 2021 · 70 investors · Other Health CareRule 506(b)
▶$10.3MraisedOct 2021 · 70 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Diane BryantDirector, Executive Officer
- Mark LaretDirector
- Nick GroufDirector
- Jeremy SohnDirector
- Stanton RoweDirector
- John DonovanDirector
- Ted KoutouzisDirector
- Offering amount
- $15M
- Amount sold
- $10.3M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$14.9MraisedJun 2020 · 38 investors · Other Health CareRule 506(b)
▶$14.9MraisedJun 2020 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nick GroufDirector
- Yuri PikoverDirector
- Jeremy SohnDirector
- Stanton J. RoweDirector
- Ted KoutouzisDirector
- Diane BryantExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $14.9M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.4MraisedMay 2019 · 109 investors · Other Health CareRule 506(b)
▶$24.4MraisedMay 2019 · 109 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ted KoutouzisDirector
- Nick GroufDirector
- Stanton J. RoweDirector
- Jeremy SohnDirector
- Leo Petrossian, Ph.D.Executive Officer, Director
- Yuri PikoverDirector
- Offering amount
- $27.9M
- Amount sold
- $24.4M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.5MraisedNov 2018 · 18 investors · Other Health CareRule 506(b)
▶$9.5MraisedNov 2018 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Yuri PikoverDirector
- Ted KoutouzisDirector
- Dongmei JiDirector
- Leo Petrossian, Ph.D.Executive Officer, Director
- Jeremy SohnDirector
- Stanton J. RoweDirector
- Nick GroufDirector
- Offering amount
- $9.5M
- Amount sold
- $9.5M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$10.1MraisedApr 2017 · 15 investors · Other Health CareRule 506(b)
▶$10.1MraisedApr 2017 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stanton J. RoweDirector
- Dongmei JiDirector
- Aaron GreenExecutive Officer
- Leo PetrossianExecutive Officer, Director
- Roy DoumaniDirector
- Jeremy SohnDirector
- Anjan ChatterjiDirector
- Ted KoutouzisDirector
- Yuri PikoverDirector
- Offering amount
- $24.9M
- Amount sold
- $10.1M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$9.3MraisedDec 2015 · 45 investors · Other Health CareRule 506(b)
▶$9.3MraisedDec 2015 · 45 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roy DoumaniDirector
- Leo PetrossianExecutive Officer, Director
- Yuri PikoverDirector
- Kenneth BakerDirector
- Mark HattendorfExecutive Officer
- Stanton RoweDirector
- Ji Dong MeiDirector
- Offering amount
- $23.6M
- Amount sold
- $9.3M
- Minimum investment
- $1
- First sale
- Dec 2015
- Incorporated
- Corporation, California, 2013
- Federal exemptions
- 06b
▶$3.1MraisedOct 2015 · 53 investors · Other Health CareRule 506(b)
▶$3.1MraisedOct 2015 · 53 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Leo PetrossianExecutive Officer, Director
- Yuri PikoverDirector
- Roy DoumaniDirector
- Mark HattendorfExecutive Officer
- Kenneth BakerDirector
- Stan RoweDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- Minimum investment
- $1
- First sale
- Apr 2014
- Incorporated
- Corporation, California, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Neural Analytics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $699.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $213.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $3M |
| National Science Foundation | Phase II | 2016 | $743.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $149.8K |
| National Science Foundation | Phase I | 2015 | $149.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Neural Analytics?
- Neural Analytics was founded by Leo Petrossian in 2013.
- Who are Neural Analytics's investors?
- Neural Analytics's investors include Alpha Edison, ARHW Holdings.
- How much funding has Neural Analytics raised?
- Neural Analytics has disclosed $81.6M raised across 7 rounds.
- Where is Neural Analytics headquartered?
- Neural Analytics is headquartered in Los Angleles, US.
